Skip to main content
. 2021 May 28;6(2):402–412. doi: 10.1002/epi4.12497

FIGURE 1.

FIGURE 1

The LT‐ACTH procedure and assessment protocol. Patients with WS who responded to the daily ACTH injections were followed up and checked whether they experienced WS relapse during/after the subsequent weekly injection period. The nonrelapse rate of WS symptoms was estimated at 24 months after the daily injection period (primary outcome). Abbreviations: LT‐ACTH, long‐term adrenocorticotropic hormone therapy; WS, West syndrome